D.E. Shaw & Co’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.85M | Buy |
508,940
+221,287
| +77% | +$2.11M | ﹤0.01% | 1456 |
|
|
2025
Q1 | $3.01M | Buy |
287,653
+153,881
| +115% | +$1.61M | ﹤0.01% | 1631 |
|
|
2024
Q4 | $3.15M | Buy |
133,772
+60,732
| +83% | +$1.43M | ﹤0.01% | 1558 |
|
|
2024
Q3 | $2.62M | Sell |
73,040
-15,380
| -17% | -$552K | ﹤0.01% | 1646 |
|
|
2024
Q2 | $3.12M | Buy |
+88,420
| New | +$3.12M | ﹤0.01% | 1511 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3192 |
|
|
2023
Q2 | – | Sell |
-23,668
| Closed | -$273K | – | 3156 |
|
|
2023
Q1 | $273K | Buy |
23,668
+10,422
| +79% | +$120K | ﹤0.01% | 2705 |
|
|
2022
Q4 | $154K | Buy |
+13,246
| New | +$154K | ﹤0.01% | 3084 |
|
|
2021
Q1 | – | Sell |
-10,280
| Closed | -$216K | – | 2999 |
|
|
2020
Q4 | $216K | Buy |
+10,280
| New | +$216K | ﹤0.01% | 2543 |
|